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A B S T R A C T
Myeloperoxidase produces strong oxidants during the immune response to destroy invading pathogens.
However, these oxidants can also cause tissue damage, which contributes to the development of numerous
inﬂammatory diseases. Selenium containing compounds, including selenomethionine (SeMet) and 1,4-anhydro-
5-seleno-D-talitol (SeTal), react rapidly with diﬀerent MPO-derived oxidants to form the respective selenoxides
(SeMetO and SeTalO). This study investigates the susceptibility of these selenoxides to undergo reduction back to
the parent compounds by intracellular reducing systems, including glutathione (GSH) and the glutathione
reductase and thioredoxin reductase systems. GSH is shown to reduce SeMetO and SeTalO, with consequent
formation of GSSG with apparent second order rate constants, k2, in the range 103–104 M−1 s−1. Glutathione
reductase reduces both SeMetO and SeTalO at the expense of NADPH via formation of GSSG, whereas
thioredoxin reductase acts only on SeMetO. The presence of SeMet and SeTal also increased the rate at which
NADPH was consumed by the glutathione reductase system in the presence of N-chloramines. In contrast, the
presence of SeMet and SeTal reduced the rate of NADPH consumption by the thioredoxin reductase system after
addition of N-chloramines, consistent with the rapid formation of selenoxides, but only slow reduction by
thioredoxin reductase. These results support a potential role of seleno compounds to act as catalytic scavengers
of MPO-derived oxidants, particularly in the presence of glutathione reductase and NADPH, assuming that
suﬃcient plasma levels of the parent selenoether can be achieved in vivo following supplementation.
1. Introduction
Neutrophils are key eﬀector cells of the innate immune response,
and are responsible for the release of bactericidal enzymes, including
myeloperoxidase (MPO), and the generation of powerful oxidants to
destroy invading pathogens [1,2]. MPO is a heme enzyme that catalyzes
the reaction between hydrogen peroxide (H2O2) and halide and
pseudohalide ions (chloride, Cl-; bromide, Br-; thiocyanate, SCN-) to
produce the corresponding hypohalous acids, hypochlorous acid
(HOCl), hypobromous acid (HOBr) and hypothiocyanous acid (HOSCN)
[1,3]. HOCl and HOBr react with amines to form the secondary
oxidants N-halamines, which can retain the oxidizing capacity of the
parent oxidants [1,4]. Although all of these species are eﬀective in
controlling or destroying pathogens, they are also capable of causing
host tissue damage, and have been associated with many inﬂammatory
diseases, including atherosclerosis, neurodegeneration, arthritis, kidney
disease and some cancers [1,5]. Given the strong association between
the generation of MPO oxidants in vivo and the development of
inﬂammatory disease, there is signiﬁcant interest in developing novel
scavengers and / or inhibitors, which may be of therapeutic beneﬁt
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(reviewed [6]).
Selenium-containing compounds, including selenomethionine
(SeMet) and 1,4-anhydro-5-seleno-D-talitol (SeTal), are potential can-
didates to limit oxidative damage during inﬂammation in vivo, on
account of their high reactivity with a number of key biological
oxidants, including HOCl, HOBr, HOSCN, N-chloramines, H2O2 and
peroxynitrous acid (ONOOH) [7-11]. The second-order rate constants
for these reactions are some of the highest reported for biologically
relevant reactions [7-11]. The reaction of SeMet with oxidants results
primarily in the formation of selenomethionine selenoxide (SeMetO),
which can be subsequently reduced by thiols such as glutathione (GSH)
(Reaction 1) [7,11-15]. Other selenoxides formed on reaction of Se
compounds with H2O2, can also be reduced by GSH, regenerating the
parent Se compound and forming GSSG [16,17], which provides a
pathway for potentially catalytic oxidant scavenging.
The reaction of SeMet with oxidants results primarily in the
formation of selenomethionine selenoxide (SeMetO), which can be
subsequently reduced by thiols such as glutathione (GSH) (Reaction
(1)) [7,11,14–17]. Other selenoxides formed on reaction of Se com-
pounds with H2O2, can also be reduced by GSH, regenerating the parent
Se compound and forming GSSG [18,19], which provides a pathway for
potentially catalytic oxidant scavenging.
SeMetO GSH SeMet GSSG H O+ 2 → + + 2 (1)
Glutathione reductase (GSR) regenerates GSH from GSSG at the
expense of NADPH, which potentially links oxidant removal with
NADPH consumption and cellular metabolism [20]. Whilst evidence
has been presented previously for selenoxide reduction by GSH [14,21],
the mechanisms and rate constants for these reactions have not been
reported. For rapid detoxiﬁcation of oxidants and prevention of
selenoxide accumulation, which would arrest the reduction cycle, it is
critical for these rate constants to be of a high value and hence
competitive with the initial reactions resulting in selenoxide formation.
SeMetO can also be reduced enzymatically, via the action of
thioredoxin reductase (TrxR) and thioredoxin (Trx) (Reaction (2))
[21]. There is evidence that other Se compounds, including ebselen,
selenocystamine and diselenides, can interact with TrxR [22,23], which
allows catalytic reduction of peroxides and ONOOH [21–23]. This
detoxiﬁcation pathway may extend to MPO-derived oxidants, including
HOCl and N-chloramines, that react rapidly with the Se compounds
SeMet and SeTal, forming selenoxides [11].
SeMetO NADPH TrxR SeMet NADP H O+ ⎯ →⎯⎯⎯⎯⎯ + ++ 2 (2)
The aim of this study was therefore to assess the catalytic oxidant
scavenging potential of SeMet and SeTal by determining rate constants
for the reduction of the corresponding selenoxides by GSH, and
investigating the interaction between the selenoxides and the enzy-
matic reductants GSR and TrxR in the presence of NADPH. The study
was subsequently extended to assess whether catalytic removal of N-
chloramines could also be mediated by SeMet and SeTal in the presence
of GSR and TrxR. The resulting data support the possibility of
supplementation with Se compounds as way to reduce oxidative
damage during chronic inﬂammatory conditions.
2. Materials and methods
2.1. Materials
All buﬀers, and solutions where indicated, were prepared using
nanopure water ﬁltered through a four-stage Milli-Q system (Millipore
Waters, Australia). Solutions were prepared in 0.1 M, pH 7.4, phosphate
buﬀer, unless otherwise speciﬁed. HOCl was prepared by dilution of a
concentrated stock solution of NaOCl (12.5% w/v; Ajax FineChem Ltd,
Australia), standardised at pH 12 by UV absorbance at 290 nm
(ε=350 M−1 cm−1 [24]). SeMet and methylselenocysteine were from
Sigma-Aldrich (Castle Hill, NSW, Australia), and 1,4-anhydro-4-seleno-
D-talitol (SeTal) was synthesised as described previously [25]. N-
acetylselenomethionine was kindly prepared by Dr Lara Malins and
seleno-bis-propionic acid was kindly provided by Prof. Indira Priyadar-
shini. Selenoxides (SeMetO, SeTalO, N-acetylselenomethionine selen-
oxide (NASMO), seleno-bis-propionic acid selenoxide (SePropO) and
methylselenocysteine selenoxide (MSCO)) were prepared by mixing the
parent Se compound (4 mM) with an equal volume of H2O2 (2 mM;
Merck, Bayswater, VIC, Australia) with incubation for 10 min at 21 °C
before dilution to the desired concentration in phosphate buﬀer (0.1 M,
pH 7.4).
2.2. Thiol quantiﬁcation
The consumption of GSH (4 µM) on addition of SeMetO and SeTalO
(0–1 µM) was assessed by measuring the change in ﬂuorescence
(λex=360 nm; λem=530 nm) of ThioGlo-1 using an M2e plate reader
(Molecular Devices) as described previously [26]. The thiol concentra-
tions were determined by comparison of the ﬂuorescence intensity to a
standard curve prepared using GSH (0–5 µM).
2.3. N-Chloramine formation and quantiﬁcation
N-chloramines were prepared by reaction of taurine (Tau), glycine
(Gly) or N-α-acetyllysine (Lys) (10 mM) with HOCl (2 mM). N-chlor-
amine concentrations were determined by measuring 5-thio-2-nitro-
benzoic acid (TNB) consumption at 412 nm as described previously
[26], using an extinction coeﬃcient ε=14,150 cm−1 [27].
2.4. Stopped-ﬂow kinetics
Stopped ﬂow kinetics experiments were carried out using an
Applied Photophysics SX.20MV stopped ﬂow system maintained at
22 °C using a thermostatted water bath. The detection system consisted
of an Xe light source (150 W; Osram GmbH, Munich, Germany) with
wavelength selection achieved using a single monochromator (slit
width, 0.5 mm; bandwidth,± 1.2 nm) and photomultiplier detection.
The system was controlled by a computer running Pro-Data SX (version
2.2.12; Applied Photophysics). Spectral data from 200 to 310 nm were
obtained by acquiring kinetic traces at 10 nm intervals with the
photomultiplier over this wavelength region. Second-order rate con-
stants were typically obtained by global analysis of the kinetic traces
using second order models with λ>240 nm using ProKIV (Applied
Photophysics, Version 1.0.1.4), although in some cases it was more
appropriate to apply pseudo-ﬁrst order analysis at selected wavelengths
to derive the rate constants.
2.5. Enzymatic NADPH consumption
The reduction of each selenoxide (200 µM) by TrxR (25 nM; IMCO,
Stockholm, Sweden) was assessed by measuring the change in absor-
bance of NADPH (700 µM; Roche, Castle Hill, NSW, Australia) at
340 nm every 30 s for 2 h using a M2e plate reader (Molecular
Devices). The rate of consumption of NADPH (700 µM) was also used
to assess the eﬀect of SeMet and SeTal (20–200 µM) on the rate of N-
chloramine (200 µM) reduction by TrxR (25 nM). An Applied
Photophysics SX.20MV stopped ﬂow system was used to quantify
NADPH (500 µM) loss upon addition of each selenoxide (200 µM) to
GSR (25 nM) and GSH (400 µM) in phosphate buﬀer (pH 7.4, 0.1 M). N-
Chloramine (200 µM) reduction experiments were also performed by
addition of SeMet or SeTal (20–200 µM) prior to exposure of the
resulting solution to the NADPH/GSR/GSH mixture. For the GSR
experiments, the loss of NADPH was measured by monitoring the
absorbance of 340 nm over 60 s with a linear slope ﬁtted to the initial
decrease in absorbance, over 2–10 s, where maximum enzymatic
activity was observed.
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2.6. Selenoxide quantiﬁcation by HPLC
Separation of SeMet and SeMetO was achieved by injection of each
sample (20 µL) onto a Beckman Ultrasphere ODS column (5 µm,
4.6×250 mm) at 40 °C with an isocratic elution method with a ﬂow
rate of 1 mL min−1 using acetonitrile (1% v/v) adjusted to pH 2.5 with
triﬂuoroacetic acid (TFA; 0.005% v/v) as described previously [17].
SeMet and SeMetO eluted at 3.2 min and 8.6 min respectively, and were
quantiﬁed by measuring the absorbance at 220 nm using a photodiode
array detector (SPD-M20A, Shimadzu). The separation of SeTal and
SeTalO was achieved by injecting samples (20 µL) onto an Agilent
Zorbax carbohydrate column (5 µm, 4.6×150 mm) at 35 °C. The
samples were eluted with an isocratic elution method with a ﬂow rate
of 1 mL min−1 using acetonitrile (75% v/v) acidiﬁed with TFA (0.005%
v/v) for 8 min, followed by a washing step whereby the H2O content in
the acetonitrile mobile phase was increased to 75% (v/v) over 1 min,
followed by elution for 3.5 min, before reducing the H2O content to
25% over 1 min, and re-equilibration for 2.5 min. SeTal and SeTalO
eluted at 2.7 min and 4.4 min respectively, and were quantiﬁed at
220 nm as described above. Samples (20 µL) containing NADPH from
the enzymatic reduction assays were injected onto an Agilent Zorbax
300SCX column (5 µm, 4.6×250 mm) at 30 °C and eluted using an
isocratic method with a mobile phase of NaH2PO4 (0.01 M, pH 4.8) and
a ﬂow rate of 1 mL min−1. Under these conditions, the retention times
for SeMet, SeMetO, SeTal and SeTalO were 3.9 min, 4.4 min, 3.4 min
and 3.7 min, respectively, with quantiﬁcation by measuring absorbance
at 220 nm.
2.7. Statistical analyses
Data are expressed as mean± standard deviation (SD) from at least
3 independent experiments, with statistical analyses performed using
one-way ANOVA with Tukey's post-hoc testing (GraphPad Prism 6,
GraphPad Software, San Diego, USA), with p<0.05 taken as a
signiﬁcant.
3. Results
3.1. Reduction of SeMet and SeTal selenoxides by GSH
Addition of increasing concentrations of SeMetO (0–1 µM, black
bars) or SeTalO (0–1 µM, grey bars) to GSH (4 µM) resulted in a dose-
dependent decrease in GSH concentrations as assessed using the
ThioGlo-1 assay (Fig. 1a). The reduction of SeMetO and SeTalO
(1.6 mM), and regeneration of SeMet and SeTal in the presence of
GSH (0–3.2 mM) were subsequently assessed by HPLC methods. The
concentration of SeMetO decreased in a dose-dependent manner upon
incubation with increasing concentrations of GSH, which resulted in a
corresponding increase in the concentrations of SeMet and GSSG
(Fig. 1b and d). The stoichiometry observed for this reaction was ca.
2:1 for GSH and SeMetO, with every 0.2 mM of SeMetO consumed
resulting in 0.2 mM SeMet and GSSG, with the consumption of 0.4 mM
GSH, in accord with previous studies [14,15]. Similar behaviour was
observed in the corresponding studies with SeTalO (1.6 mM) and GSH
(0–3.2 mM) (Fig. 1c), though in this case, quantiﬁcation of GSSG was
not possible due to interferences in the HPLC method.
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Fig. 1. Selenoxides formed on SeMet and SeTal consume GSH to produce GSSG and the parent SeMet or SeTal. (a) SeMetO (black bars) or SeTalO (grey bars) (0–1 µM) was added to GSH
(4 µM) and incubated for 10 min before remaining thiol was assessed by the ThioGlo assay. (b–d) GSH (0–3.2 mM) was added to (b,d) SeMetO (1.6 mM) or (c) SeTalO (1.6 mM) and
incubated for 10 min before analysis by HPLC and determination of concentrations of (b) SeMetO (grey bars) and SeMet (black bars), (c) SeTalO (grey bars) and SeTal (black bars), and (d)
GSSG. Data represent mean± SD from 3 independent experiments. * indicates signiﬁcant diﬀerence (p< 0.05) from the corresponding control where no selenoxide or GSH were added,
by one-way ANOVA with Tukey's post-hoc test.
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3.2. Second order rate constants for the reaction of selenoxides with thiols
Initial studies were performed using TNB as a model thiol, as TNB and
the disulﬁde product 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) have
absorbance maxima at 412 nm and 324 nm respectively, which are
distinct from the absorbance proﬁles of the selenoxides, which simpliﬁes
the kinetic analysis. SeMetO (5 µM) was mixed with increasing concentra-
tions of TNB (25–125 µM) and the absorbance monitored at 324 or
412 nm over 45 s by stopped ﬂow apparatus. A rapid decrease in
absorbance at 412 nm was observed (Fig. 2a), indicating TNB consump-
tion, with a concomitant increase in absorbance at 324 nm (Fig. 2b),
indicating DTNB formation. These changes are consistent with the reaction
of SeMetO with TNB to give SeMet and DTNB. Similar results were
obtained with SeTalO. In each case, the absorbance changes could be
satisfactorily analysed in terms of a pseudo ﬁrst-order mechanism, with
single exponential curves ﬁtting well to the experimental data. These ﬁts
yielded kobs for each condition, with the second-order rate constants
obtained from the linear plots of kobs against the initial concentration of
TNB (Fig. 2c and d for SeMetO and SeTalO; Table 1).
Complementary analyses were undertaken by converting the raw
kinetic data into linear plots of ln(Abs) vs time; these plots yielded very
similar kobs values. With both SeMetO and SeTalO, the consumption of
TNB occurs with the same rate constant as the production of DTNB,
suggesting that the mechanism involves initial reaction of one molecule
of TNB with the selenoxide with a second order rate constant k1,
followed by reaction with a second TNB molecule with a second-order
rate constant k2, to produce the reduced Se compound and DTNB as
products (Scheme 1). We also performed kinetic modelling studies that
demonstrated that in a 2-step system where the k2> k1 (for modelling
purposes a 10-fold increase of k1 over k2 was used), the thiol
concentration [RSH] decreased exponentially and the ﬁrst-order plot
was linear (Supplementary material Fig. S1). k1 could then be deter-
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Fig. 2. Kinetic analysis of the reduction of SeMetO by TNB. (a,b) Stopped ﬂow kinetic traces measured for SeMetO (5 µM) and TNB (25 µM) in phosphate buﬀer (pH 7.4, 0.1 M) using a
2 mm path length cell at 22 °C measured at (a) 412 and (b) 324 nm. A loss in absorbance was observed at 412 nm, indicating TNB consumption, with a concomitant increase in absorbance
at 324 nm, indicating DTNB formation. (c,d) The observed rate constants, kobs, were determined from the kinetic plots and kobs was plotted against the initial TNB concentration for (c)
SeMetO or (d) SeTalO. Data represent mean± SD of three independent experiments.
Table 1
Second-order rate constants for the reduction of selenoxides by TNB.
Rate constants for the reduction of selenoxides by thiols (M−1 s−1)
Selenoxide TNBa DTNBb TNBa in the presence of 10 mM Gly GSHc
SeMetO (3.8± 0.1)×104 (3.8± 0.1)×104 – k1=(1.2±0.4)×105 and k2=(1.5± 0.2)×104
SeTalO (4.9± 0.2)×103 (4.8± 0.2)×103 – (3.4±0.3)×103
MSCO (4.4± 0.3)×103 (4.9± 0.6)×103 (5.0± 0.3)×103 (2.5±0.4)×104
NASMO (1.2± 0.1)×103 (1.2± 0.1)×103 (2.5± 0.2)×103 (1.3±0.2)×103
SePropO (1.3± 0.1)×103 (1.31±0.06)×103 – (4.6±0.6)×102
a Rate constant, k, for loss of thiol.
b Rate constant, k, for formation of disulﬁde.
c Rate constant designated k1 represents the reaction of the thiol with selenoxide to form a selenosulﬁde, with k2 representing reaction of the selenosulﬁde with a second thiol to
produce the disulﬁde and selenoether.
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mined from the gradient of the pseudo ﬁrst-order plot. However, if
k1> k2, 2-phase kinetics would be observed for [RSH]. This gives a
non-linear ﬁrst-order plot, and a single exponential decay does not ﬁt to
the data well (Supplementary material Fig. S1).
The second-order rate constant determined for SeMetO with TNB is
ca. 10-fold greater than that observed for SeTalO (Table 1). This is
believed to arise from interaction of the Se centre with the lone pair of
electrons of the nitrogen atom of the amine group. Such Se-N interac-
tions are known to aﬀect the rates of reduction and oxidation of other
Se species [22,23]. Consequently, a range of other selenoxides were
examined, including the oxides of methylselenocysteine (MSCO), N-
acetylselenomethionine (NASMO) and seleno-bis-propionic acid (Se-
PropO) (Fig. 3), where such interactions would be expected to be
modulated. kobs values were determined at 412 nm from analysis of
kinetic data obtained on mixing the selenoxides (5 µM) with TNB
(25–125 µM) using single exponential ﬁtting (Supplementary material
Fig. S2; Table 1). The determined rate constants for reduction were
decreased by ~10-fold compared to SeMetO, when there was a shorter
carbon chain between the Se and the amine (MSCO), on acetylation of
the amine (NASMO) or removal of the amine (SePropO).
The eﬀect of Se-N interactions was further examined by determining
the second-order rate constants for reduction of the selenoxides MSCO
and NASMO by TNB in phosphate buﬀer (0.1 M, pH 7.4) supplemented
with Gly (10 mM), as an extramolecular source of amine. The k2 value
for MSCO under these conditions was essentially unchanged compared
to the absence of Gly (Supplementary material Fig. S2, Table 1),
whereas that for NASMO was signiﬁcantly increased in the presence
of Gly, suggesting that Se-N interactions may promote selenoxide
reduction by thiols.
Analogous studies were performed to assess the reactivity of
SeMetO, SeTalO and other selenoxides (125 µM) with GSH
(0.5–2.5 mM) by monitoring absorbance changes by stopped ﬂow at
wavelengths between 240 and 300 nm (at 10 nm intervals). For SeTalO,
MSCO, NASMO and SePropO, increases in absorbance across these
wavelengths were observed (data for SeTalO shown in Fig. 4a and b).
The observed changes in absorbance yielded a linear plot of ln(Abs) vs
time, and could be ﬁtted to a single exponential function to yield the
kobs values at each GSH concentration. The reported k2 values for the
reduction of SeTalO, MSCO, NASMO and SePropO (Table 1) were
determined by global analysis of the absorbance changes from 240 to
300 nm using the mechanism outlined in Reaction (3). These data are
consistent with the initial reaction of the selenoxide being the rate
determining step, as seen with TNB.
Selenoxide RSH k Product+ →1 (3)
In contrast, the kinetic traces observed for the reduction of SeMetO
by GSH were more complex, with absorbance changes showing two
separate phases on mixing SeMetO (125 µM) with GSH (0.5–2.5 mM).
Representative kinetic data with GSH (0.5 mM) are shown in Fig 4c and
d. At 240 nm, there was a fast initial decrease in absorbance over ca.
20 ms, which was followed by a subsequent increase in absorbance over
ca. 200 ms (Fig. 4d). These separate phases were also observed across a
range of other wavelengths, but in these cases both phases exhibited
increases in absorbance intensity (data not shown). The kinetic data
with SeMetO and GSH are consistent with the mechanism proposed in
Scheme 1, but with k2< k1. The value of k1 was determined by pseudo
ﬁrst-order analysis of the initial decrease in absorbance observed at
240 nm (Supplementary material Fig. S3). The resulting k1 value was
used during global wavelength analysis of the data to decrease the
number of unknown parameters in Reaction (4). These analysis
methods yielded values of k1=(1.2± 0.4)×105 M−1 s−1 and k2=
(1.5± 0.2)×104 M−1 s−1 for the reduction of SeMetO by GSH.
Selenoxide GSH k Intermediate GSH k Products+ → + →1 2 (4)
3.3. Reduction of selenoxides by the thioredoxin reductase system
The ability of TrxR to reduce SeMetO and SeTalO was compared, as
it has been reported previously that this enzymatic system can reduce
SeMetO [21]. The reduction of SeMetO and SeTalO (200 µM) by TrxR
(25 nM) in the presence of NADPH (700 µM) was examined by
measuring the consumption of the latter at 340 nm (Fig. 5a), with the
data obtained over the ﬁrst 10 min ﬁtted to a straight line. The addition
of SeMetO induced an increase in NADPH consumption, but no change
was observed with SeTalO (Fig. 5b). The reduction of SeMetO and
SeTalO by TrxR was examined further by HPLC to assess the concen-
tration of SeMetO, SeTalO, SeMet and SeTal 2 h after addition of
SeMetO or SeTalO to TrxR in the presence of NADPH (700 µM).
Evidence was obtained for the complete reduction of the SeMetO, with
a corresponding increase in SeMet concentration, whereas no changes
in the SeTalO or SeTal concentrations were observed, consistent with
the kinetic data. This suggests that while TrxR can reduce SeMetO,
Scheme 1. Proposed two-step mechanism of selenoxide reduction by thiols. Initial reaction of selenoxides (A) with thiols is proposed to lead to the formation of a seleno-sulﬁde
intermediate (B). The rate constant for the initial reaction is designated as k1. A second thiol then reacts with the intermediate with a rate constant k2, producing a selenoether (C),
disulﬁde (D) and water (E) as products.
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SeTalO is not a substrate.
Experiments were also performed by co-incubating SeMetO and
SeTalO with TrxR in the presence of NADPH and other components of
cellular reduction and repair systems, including Trx (1.5 µM), glu-
tathione peroxidase (GPx, 1.5 µM) and methionine sulfoxide reductases
(MsrA, 95 nM; MsrB2, 0.25 µM). However, inclusion of these enzymes
did not increase either the rate of NADPH consumption (assessed by
absorbance at 340 nm), or the quantity of selenoxide reduced (as
measured by HPLC; data not shown).
3.4. Reduction of selenoxides by the glutathione reductase system
The reduction of selenoxides by GSH results in the formation of
GSSG (Fig. 1d), therefore the ability of the GSR system (NADPH/GSR/
GSH) to reduce SeMetO and SeTalO was assessed. Given the rapid rate
of reaction of selenoxides with GSH, SeMetO and SeTalO (200 µM) were
Fig. 3. Structures of selenoxides used in the determination of the mechanisms and kinetics of selenoxide reduction by thiols.
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mixed with the GSR assay mixture (500 µM NADPH, 25 nM GSR and
400 µM GSH) using a stopped ﬂow apparatus to determine the
consumption of NADPH at 340 nm over a period of 1 min (Fig. 6a).
The initial rate of NADPH consumption was determined by ﬁtting a
straight line to the ﬁrst 10 s of data. NADPH was consumed at a rate of
9.1± 1 or 8.3± 0.3 mAbs s−1 upon mixing SeMetO or SeTalO respec-
tively (Fig. 6b).
In order to conﬁrm that NADPH consumption reﬂects recycling of
the GSSG by GSR following SeMetO reduction by GSH, SeMetO
(200 µM) was incubated with the GSR system (500 µM NADPH,
25 nM GSR and 400 µM GSH) for 10 min before analysis by HPLC.
Over this period, all the SeMetO was consumed, with a concomitant
increase (200 µM) in the SeMet concentration, consistent with rapid
reduction of SeMetO by GSH and recycling with the GSR/NADPH
system (data not shown). Analogous experiments could not be per-
formed with SeTalO, as components of the GSR system co-elute with
SeTalO and SeTal (data not shown).
3.5. N-Chloramine consumption in SeMet/SeTal supplemented enzymatic
reduction systems
The eﬀect of SeMet and SeTal on the rate of TrxR reduction of a
series of N-chloramines was examined, as these oxidants react rapidly
with SeMet and SeTal to form selenoxides [11]. Chloramines were
formed on taurine (TauCl), N-α-acetyllysine (LysCl) and glycine (GlyCl)
by reaction of the parent amine (10 mM) with HOCl (2 mM) before
dilution (200 µM chloramine) and addition to NADPH (700 µM) and
TrxR (25 nM) in the presence or absence of SeMet or SeTal (20 or
200 µM). The absorbance was monitored for 2 h at 340 nm and the rate
of NADPH consumption determined by ﬁtting a straight line to the
initial 25 min of absorbance data (Fig. 7, Supplementary material Fig.
S4). With TauCl, the rate of NADPH consumption was similar in the
presence and absence of TrxR (Fig. 7a and b). Reaction of TauCl with
SeMet or SeTal (20–200 µM) resulted in a signiﬁcant, dose-dependent,
decrease in the rate of NADPH consumption observed (Fig. 7b). Similar
results were obtained with LysCl and GlyCl (Supplementary material
Fig. S4). SeTal (200 µM) reduced the rate of NADPH consumption seen
with TauCl to the same rate as controls, whereas SeMet (200 µM)
reduced the rate of NADPH consumption to that observed after the
addition of pre-formed SeMetO to the TrxR system (see Fig. 5). These
data are consistent with competition of SeMet/SeTal and NADPH/TrxR
for the N-chloramines, with subsequent TrxR-mediated reduction of the
resulting selenoxides, in the case of SeMet.
The concentrations of SeMet, SeMetO, SeTal and SeTalO were
assessed by HPLC 20 min and 2 h after the addition of TauCl to the
NADPH (700 µM), TrxR (25 nM) system supplemented with SeMet or
SeTal (200 µM) (Fig. 7c). After 20 min, the major species detected were
the selenoxides (164±8 µM SeMetO and 175±6 µM SeTalO). After
2 h, the concentration of SeMetO decreased to 12±13 µM, with a
corresponding increase observed in SeMet levels, which has been
attributed to SeMetO reduction by TrxR (Fig. 7c). In contrast, SeTalO
levels were unchanged, reﬂecting the inability of TrxR to reduce SeTalO
(Fig. 7d).
These studies were extended to examine the eﬀect of SeMet and
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SeTal addition on the rate of N-chloramine reduction by the GSR
system. In this case, TauCl, LysCl or GlyCl (200 µM) were mixed by
stopped ﬂow apparatus with NADPH (500 µM), GSR (25 nM), and GSH
(400 µM) in the presence or absence of SeMet or SeTal (20 or 200 µM).
The rate of consumption of NADPH was determined by ﬁtting a straight
line to the absorbance data obtained 2–10 s after mixing. A time-
dependent decrease in NADPH absorbance at 340 nm was observed on
mixing TauCl, LysCl or GlyCl with the components of the GSR system
(Fig. 8, Supplementary material Fig. S5). In the presence of SeMet
(200 µM), a signiﬁcant increase in the rate of NADPH consumption was
observed compared to that seen with TauCl alone (Fig. 8b). A similar,
but non-signiﬁcant, trend was observed with SeTal. However, there was
no change in the rate of NADPH consumption mediated by the GSR
system in the presence or absence of SeMet and SeTal in experiments
with LysCl and GlyCl (Supplementary material Fig. S5).
The concentrations of SeMet and SeMetO were assessed by HPLC
10 min after addition of TauCl, LysCl and GlyCl (200 µM) to NADPH
(500 µM), GSR (25 nM), and GSH (400 µM) in the presence of SeMet
(200 µM). Under these conditions, no SeMetO was detected, with
complete recovery of SeMet observed (Fig. 8c). These data suggest that
for TauCl at least, the presence of SeMet may be able to enhance the
reduction of the N-chloramine by the GSR system via formation of a
selenoxide.
4. Discussion
In this study, we show that the selenoxides formed on SeMet, SeTal
and other Se compounds are rapidly reduced by endogenous low-
molecular mass thiols. We also provide evidence for enzymatic reduc-
tion of SeMetO, but not SeTalO, by the TrxR/NADPH system, whereas
both selenoxides were rapidly reduced by a GSR/NADPH system. The
rapid enzymatic reduction of SeMetO also allowed SeMet to promote
the reduction of N-chloramines.
We show that GSH is capable of reducing SeMetO to SeMet with
concomitant formation of GSSG, consistent with previous studies
[14,15]. Reduction of SeMetO or SeTalO by GSH occurs with similar
stoichiometries, with 1 mol of selenoxide consumed and 1 mol of parent
selenoether recovered for every 2 mol of GSH. The kinetic analysis
supports a two-step reaction mechanism, where one thiol reacts with
the selenoxide to form a selenosulﬁde with rate constant k1. This
intermediate then reacts with a second thiol to give the disulﬁde and
selenoether, with rate constant k2 (Scheme 1). This process is more
clearly observed on reaction of SeMetO with GSH, where an initial
rapid decrease in absorbance (at 240 nm) is observed, corresponding to
the ﬁrst reaction, followed by a slower increase in absorbance,
attributed to the second reaction (Fig. 4d). The derived rate constant,
k2, for the second step (~104 M−1 s−1) is an order of magnitude lower
than k1 for the ﬁrst step for SeMetO with GSH (Table 1). This results in
Fig. 7. Reduction of N-chloramines by the TrxR system in the presence of SeMet or SeTal. Panel (a) shows typical absorbance decrease of NADPH observed at 340 nm over time on
addition of TauCl (200 µM) to NADPH (700 µM; solid line) in the presence of TrxR (25 nM; dot-dashed line) and SeMet (200 µM; dashed line) or SeTal (200 µM; dotted line). Panel (b)
shows the rate of consumption of NADPH measured by ﬁtting a straight line to the ﬁrst 25 min of the data presented in (a), with data from experiments performed with 20 µM (white bars)
and 200 µM (grey bars) SeMet and SeTal. Panel (c) shows the recovery of SeMet (black bars) from SeMetO (white bars) as determined by HPLC after TauCl was added to TrxR/NADPH in
the presence of 200 µM SeMet. Panel (d) is as (c) but with SeTal. For panels (b)–(d), data represent mean± SD from 3 independent experiments. * Indicates signiﬁcant diﬀerence
(p< 0.05) from the control by one-way ANOVA with Tukey's post-hoc test.
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kinetic traces that have two distinct ﬁrst order phases, which is
consistent with both phases being dependent on the thiol concentration
that is present in excess (Fig. S3). The data obtained for the other
selenoxides are consistent with this mechanism, assuming that the rate
constant k2 for the second step is signiﬁcantly greater than k1 for the
ﬁrst step, resulting in rapid reaction of the intermediate and kinetic
traces that appear ﬁrst order with only a single phase. It is also possible
that a mechanism involving a fast equilibrium between the selenoxide
and selenosulﬁde could play a role.
A selenosulﬁde has been proposed as an intermediate in the
reactions of selenoxides with thiols. However, these intermediates have
not been characterized, as selenosulﬁdes react rapidly with thiols to
give disulﬁdes and selenols as products [28]. This disulﬁde exchange
mechanism is analogous to that of TrxR [29]. Similar intermediates
have been proposed in the reduction of methionine sulfoxide (MetSO)
by Se-containing methionine sulfoxide reductase (Msr) enzymes
[29–31]. Previously published rate constants for reaction of low-
molecular mass thiols with selenosulﬁdes have been obtained from
extrapolation of experimental data based on thermodynamic calcula-
tions, with the rate constant for reaction of DTT with hemi-selenocys-
tine reported as ~10 M−1 s−1 [28]. In contrast the rate constant
determined here for the second step of the SeMetO reaction with GSH
is ~104 M−1 s−1. During selenoxide reduction, the selenosulﬁde inter-
mediate is proposed to retain the oxygen bound to Se (Scheme 1,
Compound B). This electronegative oxygen atom bound to the Se centre
may contribute to the electrophilicity of the Se atom by withdrawing
electrons, leading to a more rapid nucleophilic reaction of the second
thiol [28]. Similarly, the reaction of the Sec catalytic domain of TrxR
with active thioredoxin occurs with k 107–108 M−1 min−1 [32,33],
though this high value is likely to reﬂect the inﬂuence of the
surrounding protein structure and microenvironment [28].
Evidence has also been obtained for the enzymatic reduction of
selenoxides by TrxR and GSR in the presence of NADPH. The TrxR
system reduces SeMetO, but not SeTalO, whereas the GSR system
rapidly reduces both SeMetO and SeTalO. This may be related to an
inﬂuence of the selenosugar structure on the kinetics, as the reaction
should be thermodynamically favourable, given the higher reduction
potential of selenols compared to thiols. SeTalO may be subject to steric
hindrance in accessing the active site of TrxR, though the active site of
TrxR is on a ﬂexible tail [34]. However, if the site of reduction of
SeMetO in TrxR is the N-terminal Cys-X-X-Cys redox centre [34], rather
than the active site selenol, this may limit the accessibility of SeTalO for
reduction. With GSR, reduction occurs after an initial lag phase (< 1 s),
attributed to the formation of GSSG by the reaction of the SeMetO and
SeTalO with GSH. The GSSG is then reduced by GSR, resulting in the
consumption of NADPH. The rate of NADPH consumption was more
rapid with GSR than TrxR, consistent with the former enzyme system
being the more likely mechanism for selenoxide repair in vivo.
The addition of Trx to the TrxR/NADPH/SeMetO system did not
increase the rate of selenoxide reduction, in contrast to previous reports
[21]. This may reﬂect diﬀerences in the concentration and type of Trx
used, though addition of Trx together with GPx, MsrA or MsrB2 was
also unable to increase the rate at which NADPH was consumed upon
addition of SeMetO or SeTalO. This could reﬂect that the reduction of
TrxR by NADPH is the limiting factor in the reduction cycle, such that
NADPH consumption is not increased with the addition of coupled
enzymatic systems. However, this may be unlikely given that other Trx/
TrxR/NADPH-dependent reactions proceed more rapidly under analo-
gous conditions. Thus, an alternative explanation is that the kinetics of
the reaction of SeMetO with TrxR may be greater than that observed for
the other enzymes, with TrxR preferentially reducing SeMetO directly.
We also show that N-chloramines can be reduced enzymatically via
the TrxR and GSR systems, which results in the consumption of NADPH.
In this case, a time-dependent decrease in NADPH concentration, due to
the direct reaction of NADPH with N-chloramines, is also observed in
the absence of TrxR and GSR. These data agree with previous studies,
where the reaction of NADPH with various N-chloramines occurs with
k~1 M−1 s−1 [35,36], and results in the formation of a chlorinated
NADPH product that is toxic to cells [37]. Addition of SeMet or SeTal
lowered the NADPH consumption rate after addition of N-chloramines
to NADPH and TrxR to a rate similar to that observed in the selenoxide
reduction experiments. This reﬂects reaction of N-chloramines with
SeMet and SeTal, followed by the slower reduction of the resulting
selenoxide (or no reduction as with SeTalO). This is achieved on
addition of SeMet/SeTal at concentrations equimolar to that of the N-
chloramine, in the presence of an excess (3.5-fold) of NADPH.
Detoxiﬁcation of the N-chloramine via this pathway would also be
expected to decrease formation of the toxic chlorinated NADPH
product, and subsequently increase cellular NADP+. Rapid reduction
of the model N-chloramines was also observed with the GSR system,
which for TauCl at least, increased in the presence of SeMet. This may
be related to the lower rate constant for reaction of this N-chloramine
with GSH [13]. Taken together, these data suggest that the addition of
selenium compounds will have a limited capacity to increase detox-
iﬁcation of N-chloramines via this pathway.
The ability of other selenium compounds, such as ebselen and
Fig. 8. Reduction of chloramines by the GSR system in the presence of SeMet or SeTal.
Panel (a) shows the typical decrease of NADPH measured at 340 nm over time on addition
of TauCl (200 µM; solid line), to GSR (25 nM), GSH (400 µM) and NADPH (500 µM) in the
presence of SeMet (200 µM; dashed line) or SeTal (200 µM; dotted line) using a stopped-
ﬂow system with 2 mm path length cell. Panel (b) shows the initial rate of absorbance
decrease over the ﬁrst 10 s of data represented in (a), with data from experiments
performed with 20 µM (white bars) and 200 µM (grey bars) SeMet and SeTal. For panel
(b), data represent mean± SD from 3 independent experiments. * Indicates signiﬁcant
diﬀerence (p<0.05) from the control by one-way ANOVA with Tukey's post-hoc test.
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selenocystamine, to enhance oxidant scavenging has previously been
reported, though these function via a diﬀerent mechanism to that
discussed here [22,38,39]. It is proposed that the redox enzymes,
including Trx and GSR, reduce the diselenides or ebselen to a selenol
group, which then rapidly reacts with the oxidant to reform the parent
compound [22,38,39]. Ebselen was more eﬀective at oxidant removal
in conjunction with the Trx system compared to the GSR system [39],
while the opposite was observed for SeMet and SeTal. This is consistent
with the diﬀering mechanism proposed for SeMet and SeTal, where the
parent species react directly with the oxidant to form selenoxides,
followed by reduction by the enzymes or GSH to reform the parent
compound.
In summary, we have deﬁned the rate constants for reaction of
SeMetO and SeTalO with GSH and other thiols, and demonstrated the
potential for other endogenous antioxidant systems, including GSR and
TrxR, to recycle these intermediates to the parent selenium species. The
ability of selenium-containing compounds such as SeMet and SeTal to
prevent oxidative damage in vivo will however, be dependent on the
levels of these species that can be achieved on supplementation. Given
that the rate constants for reaction of selenium-containing compounds
with oxidants, including MPO-derived species, are in general 10–100-
fold greater than for the analogous reactions with thiol-containing
compounds (e.g. HOSCN [8,40], N-chloramines [11,13]), lower con-
centrations of SeMet/SeTal should be able to compete with other
biological targets, including thiols. This is supported by recent in vivo
studies in SeTal supplemented, atherosclerosis-prone apoE-/- mice,
where plasma levels of SeTal of 5–10 µM were achieved on supple-
mentation with non-toxic doses of SeTal, which is only slightly below
plasma GSH levels (10–15 µM) with LC-MS/MS data demonstrating the
formation of SeTalO on prolonged incubation of the isolated plasma
resulting from autoxidation reactions (Zacharias et al., unpublished).
However, further in vivo studies are required to determine the
therapeutic potential of SeMet and SeTal to mitigate oxidative damage
during chronic inﬂammation and assess the subsequent eﬀects on the
extent of disease development.
Acknowledgements
The authors would like to thank Dr Lara Malins and Professor
Richard Payne (University of Sydney, Australia) for synthesising N-
acetylselenomethionine and Professors Indira Priyadarsini and Vimal K.
Jain (Bhabha Atomic Research Centre, India) for synthesising the
seleno-bis-propionic acid used in this study. This work was supported
by the Australian Research Council, through the Centre's of Excellence
(CE0561607) and Future Fellowship (FT120100682) schemes, and the
Novo Nordisk Foundation (grants NNF13OC0004294 and
NNF15OC0018300 to M.J.D). L.C. is grateful to the University of
Sydney for the provision of an Australian Postgraduate Award
Scholarship.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.redox.2017.04.023.
References
[1] M.J. Davies, C.L. Hawkins, D.I. Pattison, M.D. Rees, Mammalian heme peroxidases:
from molecular mechanisms to health implications, Antioxid. Redox Signal. 10
(2008) 1199–1234.
[2] M.B. Hampton, A.J. Kettle, C.C. Winterbourn, Inside the neutrophil phagosome:
oxidants, myeloperoxidase, and bacterial killing, Blood 92 (1998) 3007–3017.
[3] B.S. Rayner, D.T. Love, C.L. Hawkins, Comparative reactivity of myeloperoxidase-
derived oxidants with mammalian cells, Free Radic. Biol. Med. 71 (2014) 240–255.
[4] E.L. Thomas, M.B. Grisham, M.M. Jeﬀerson, Preparation and characterization of
chloramines, Methods Enzymol. 132 (1986) 569–585.
[5] S.J. Klebanoﬀ, Myeloperoxidase: friend and foe, J. Leukoc. Biol. 77 (2005)
598–625.
[6] T. Lazarevic-Pasti, A. Leskovac, V. Vasic, Myeloperoxidase inhibitors as potential
drugs, Curr. Drug Metab. 16 (2015) 168–190.
[7] S. Padmaja, G.L. Squadrito, J.N. Lemercier, R. Cueto, W.A. Pryor, Rapid oxidation
of DL-selenomethionine by peroxynitrite, Free Radic. Biol. Med. 21 (1996)
317–322.
[8] O. Skaﬀ, D.I. Pattison, P.E. Morgan, R. Bachana, V.K. Jain, K.I. Priyadarsini,
M.J. Davies, Selenium-containing amino acids are targets for myeloperoxidase-
derived hypothiocyanous acid: determination of absolute rate constants and
implications for biological damage, Biochem. J. 441 (2012) 305–316.
[9] C. Storkey, M.J. Davies, D.I. Pattison, Reevaluation of the rate constants for the
reaction of hypochlorous acid (HOCl) with cysteine, methionine, and peptide
derivatives using a new competition kinetic approach, Free Radic. Biol. Med. 73
(2014) 60–66.
[10] C. Storkey, D.I. Pattison, J.M. White, C.H. Schiesser, M.J. Davies, Preventing protein
oxidation with sugars: scavenging of hypohalous acids by 5-selenopyranose and 4-
selenofuranose derivatives, Chem. Res. Toxicol. 25 (2012) 2589–2599.
[11] L. Carroll, D.I. Pattison, S. Fu, C.H. Schiesser, M.J. Davies, C.L. Hawkins, Reactivity
of selenium-containing compounds with myeloperoxidase-derived chlorinating
oxidants: second-order rate constants and implications for biological damage, Free
Radic. Biol. Med. 84 (2015) 279–288.
[12] D.I. Pattison, M.J. Davies, Absolute rate constants for the reaction of hypochlorous
acid with protein side chains and peptide bonds, Chem. Res. Toxicol. 14 (2001)
1453–1464.
[13] A.V. Peskin, C.C. Winterbourn, Kinetics of the reactions of hypochlorous acid and
amino acid chloramines with thiols, methionine, and ascorbate, Free Radic. Biol.
Med. 30 (2001) 572–579.
[14] A. Assmann, K. Briviba, H. Sies, Reduction of methionine selenoxide to seleno-
methionine by glutathione, Arch. Biochem. Biophys. 349 (1998) 201–203.
[15] R.J. Krause, A.A. Elfarra, Reduction of L-methionine selenoxide to seleno-L-
methionine by endogenous thiols, ascorbic acid, or methimazole, Biochem.
Pharmacol. 77 (2009) 134–140.
[16] B. Gammelgaard, C. Cornett, J. Olsen, L. Bendahl, S.H. Hansen, Combination of LC-
ICP-MS, LC-MS and NMR for investigation of the oxidative degradation of
selenomethionine, Talanta 59 (2003) 1165–1171.
[17] R.J. Krause, S.C. Glocke, A.R. Sicuri, S.L. Ripp, A.A. Elfarra, Oxidative metabolism
of seleno-L-methionine to L-methionine selenoxide by ﬂavin-containing monoox-
ygenases, Chem. Res. Toxicol. 19 (2006) 1643–1649.
[18] F. Kumakura, B. Mishra, K.I. Priyadarsini, M. Iwaoka, A water-soluble cyclic
selenide with enhanced glutathione peroxidase-like catalytic activities, Eur. J. Org.
Chem. (3) (2010) 440–445.
[19] K. Arai, F. Kumakura, M. Takahira, N. Sekiyama, N. Kuroda, T. Suzuki, M. Iwaoka,
Eﬀects of ring size and polar functional groups on the glutathione peroxidase-like
antioxidant activity of water-soluble cyclic selenides, J. Org. Chem. 80 (2015)
5633–5642.
[20] I. Carlberg, B. Mannervik, Glutathione-reductase, Methods Enzymol., 113, 1985,
pp. 484–490.
[21] A.S. Rahmanto, M.J. Davies, Catalytic activity of selenomethionine in removing
amino acid, peptide, and protein hydroperoxides, Free Radic. Biol. Med. 51 (2011)
2288–2299.
[22] M. Bjornstedt, S. Kumar, A. Holmgren, Selenodiglutathione is a highly eﬃcient
oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin
reductase, J. Biol. Chem. 267 (1992) 8030–8034.
[23] M. Bjornstedt, M. Hamberg, S. Kumar, J. Xue, A. Holmgren, Human thioredoxin
reductase directly reduces lipid hydroperoxides by NADPH and selenocystine
strongly stimulates the reaction via catalytically generated selenols, J. Biol. Chem.
270 (1995) 11761–11764.
[24] J.C. Morris, Acid ionization constant of HOCl from 5 to 35 degrees, J. Phys. Chem.
70 (1966) 3798–3805.
[25] C. Storkey, M.J. Davies, J.M. White, C.H. Schiesser, Synthesis and antioxidant
capacity of 5-selenopyranose derivatives, Chem. Commun. 47 (2011) 9693–9695.
[26] C.L. Hawkins, P.E. Morgan, M.J. Davies, Quantiﬁcation of protein modiﬁcation by
oxidants, Free Radic. Biol. Med. 46 (2009) 965–988.
[27] P. Eyer, F. Worek, D. Kiderlen, G. Sinko, A. Stuglin, V. Simeon-Rudolf, E. Reiner,
Molar absorption coeﬃcients for the reduced Ellman reagent: reassessment, Anal.
Biochem. 312 (2003) 224–227.
[28] D. Steinmann, T. Nauser, W.H. Koppenol, Selenium and sulfur in exchange
reactions: a comparative study, J. Org. Chem. 75 (2010) 6696–6699.
[29] R.J. Hondal, S.M. Marino, V.N. Gladyshev, Selenocysteine in thiol/disulﬁde-like
exchange reactions, Antioxid. Redox Signal. 18 (2013) 1675–1689.
[30] A. Olry, S. Boschi-Muller, M. Marraud, S. Sanglier-Cianferani, A. Van Dorsselear,
G. Branlant, Characterization of the methionine sulfoxide reductase activities of
PILB, a probable virulence factor from Neisseria meningitidis, J. Biol. Chem. 277
(2002) 12016–12022.
[31] S. Boschi-Muller, A. Olry, M. Antoine, G. Branlant, The enzymology and biochem-
istry of methionine sulfoxide reductases, Biochim. Biophys. Acta 1703 (2005)
231–238.
[32] L.W. Zhong, A. Holmgren, Essential role of selenium in the catalytic activities of
mammalian thioredoxin reductase revealed by characterization of recombinant
enzymes with selenocysteine mutations, J. Biol. Chem. 275 (2000) 18121–18128.
[33] B.E. Eckenroth, B.M. Lacey, A.P. Lothrop, K.M. Harris, R.J. Hondal, Investigation of
the C-terminal redox center of High-M-r thioredoxin reductase by protein en-
gineering and semisynthesis, Biochemistry 46 (2007) 9472–9483.
[34] L.W. Zhong, E.S.J. Arner, A. Holmgren, Structure and mechanism of mammalian
thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulﬁde
formed from the conserved cysteine-selenocysteine sequence, Proc. Natl. Acad. Sci.
USA 97 (2000) 5854–5859.
L. Carroll et al. Redox Biology 12 (2017) 872–882
881
[35] W.A. Prutz, R. Kissner, W.H. Koppenol, H. Rueegger, On the irreversible destruction
of reduced nicotinamide nucleotides by hypohalous acids, Arch. Biochem. Biophys.
380 (2000) 181–191.
[36] W.A. Prutz, Interaction of hypochlorous acid with pyrimidine nucleotides, and
secondary reactions of chlorinated pyrimidines with GSH, NADH, and other
substrates, Arch. Biochem. Biophys. 349 (1998) 183–191.
[37] B.W. Griﬃn, R. Haddox, Chlorination of NADH – similarities of the HOCl-supported
and chloroperoxidase-catalyzed reactions, Arch. Biochem. Biophys. 239 (1985)
305–309.
[38] R. Zhao, A. Holmgren, A novel antioxidant mechanism of ebselen involving ebselen
diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase, J.
Biol. Chem. 277 (2002) 39456–39462.
[39] R. Zhao, H. Masayasu, A. Holmgren, Ebselen: a substrate for human thioredoxin
reductase strongly stimulating its hydroperoxide reductase activity and a superfast
thioredoxin oxidant, Proc. Natl. Acad. Sci. USA 99 (2002) 8579–8584.
[40] O. Skaﬀ, D.I. Pattison, M.J. Davies, Hypothiocyanous acid reactivity with low-
molecular-mass and protein thiols: absolute rate constants and assessment of
biological relevance, Biochem. J. 422 (2009) 111–117.
L. Carroll et al. Redox Biology 12 (2017) 872–882
882
